Morgan Stanley Capital Partners Invests in US HealthConnect

October 29, 2020

Investment funds managed by Morgan Stanley Capital Partners completed an investment in US HealthConnect, partnering with founder-led management while Frank Russomano remains President and CEO. US HealthConnect is a digital medical education and engagement-data platform serving pharmaceutical, biotech, diagnostic, and device companies; the investment is intended to support platform and capability expansion.

Buyers
Morgan Stanley Capital Partners
Targets
US HealthConnect
Location
Pennsylvania, United States
Transaction Type
Growth capital

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.